Literature DB >> 28645833

Binding Kinetics and Pathways of Ligands to GPCRs.

Andrea Strasser1, Hans-Joachim Wittmann2, Roland Seifert3.   

Abstract

Previously, drugs were developed focusing on target affinity and selectivity. However, it is becoming evident that the drug-target residence time, related to the off-rate, is an important parameter for successful drug development. The residence time influences both the on-rate and overall effectiveness of drugs. Furthermore, ligand binding is now appreciated to be a multistep process because metastable and/or intermediate binding sites in the extracellular region have been identified. In this review, we summarize experimental ligand-binding data for G-protein-coupled receptors (GPCRs), and their binding pathways, analyzed by molecular dynamics (MD). The kinetics of drug binding to GPCRs are complex and depend on several factors, including charge distribution on the receptor surface, ligand-receptor interactions in the binding channel and the binding site, or solvation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Keywords:  GPCR; molecular dynamics; residence time

Mesh:

Substances:

Year:  2017        PMID: 28645833     DOI: 10.1016/j.tips.2017.05.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  23 in total

1.  Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.

Authors:  Angela Arsova; Thor C Møller; Line Vedel; Jakob Lerche Hansen; Simon R Foster; Karen J Gregory; Hans Bräuner-Osborne
Journal:  Mol Pharmacol       Date:  2020-05-01       Impact factor: 4.436

2.  Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes.

Authors:  Carrie German; Minu Pilvankar; Andrzej Przekwas
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-08-08       Impact factor: 2.745

3.  Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2019-04-08       Impact factor: 4.436

4.  Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions.

Authors:  Nan Chiang; Elena Barnaeva; Xin Hu; Juan Marugan; Noel Southall; Marc Ferrer; Charles N Serhan
Journal:  Cell Chem Biol       Date:  2018-12-13       Impact factor: 8.116

Review 5.  Link between a high k on for drug binding and a fast clinical action: to be or not to be?

Authors:  Georges Vauquelin
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

Review 6.  Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder.

Authors:  Jean-Michel Azorin; Nicolas Simon
Journal:  Drugs       Date:  2019-10       Impact factor: 9.546

7.  Binding of histamine to the H1 receptor-a molecular dynamics study.

Authors:  Christian A Söldner; Anselm H C Horn; Heinrich Sticht
Journal:  J Mol Model       Date:  2018-11-29       Impact factor: 1.810

8.  An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury.

Authors:  Xiao-Jing Zhang; Xu Cheng; Zhen-Zhen Yan; Jing Fang; Xiaozhan Wang; Weijun Wang; Zhen-Yu Liu; Li-Jun Shen; Peng Zhang; Pi-Xiao Wang; Rufang Liao; Yan-Xiao Ji; Jun-Yong Wang; Song Tian; Xue-Yong Zhu; Yan Zhang; Rui-Feng Tian; Lin Wang; Xin-Liang Ma; Zan Huang; Zhi-Gang She; Hongliang Li
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

9.  Deciphering the Agonist Binding Mechanism to the Adenosine A1 Receptor.

Authors:  Giuseppe Deganutti; Kerry Barkan; Barbara Preti; Michele Leuenberger; Mark Wall; Bruno G Frenguelli; Martin Lochner; Graham Ladds; Christopher A Reynolds
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-21

10.  Binding pathway determines norepinephrine selectivity for the human β1AR over β2AR.

Authors:  Xinyu Xu; Jonas Kaindl; Mary J Clark; Harald Hübner; Kunio Hirata; Roger K Sunahara; Peter Gmeiner; Brian K Kobilka; Xiangyu Liu
Journal:  Cell Res       Date:  2020-10-22       Impact factor: 46.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.